Toluenesulfonyl-Oxytocin and Oxytocin Dimer represent modified oxytocin derivatives used to study protective-group effects and higher-order peptide assembly. The toluenesulfonyl group alters charge and reactivity, while dimer formation affects conformational stability. Researchers examine their chromatographic and spectroscopic signatures. Applications include impurity profiling, synthetic intermediate analysis, and supramolecular peptide behavior.
CAT No: R2807
Synonyms/Alias:3,3'-((4S,7R,10S,13R,16S,19R,24S,27R,30S,33R,36S,39R)-19-amino-7,36-bis(2-amino-2-oxoethyl)-39-((R)-2-(((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-4-((S)-2-(((R)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-13-((R)-sec-butyl)-30-((S)-sec-butyl)-16,27-bis(4-hydroxybenzyl)-24-(4-methylphenylsulfonamido)-6,9,12,15,18,25,28,31,34,37-decaoxo-1,2,21,22-tetrathia-5,8,11,14,17,26,29,32,35,38-decaazacyclotetracontane-10,33-diyl)dipropanamide
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More